SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-003288
Filing Date
2022-03-10
Accepted
2022-03-10 07:11:51
Documents
88
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K gmtx-20211231.htm   iXBRL 10-K 3710784
2 EX-4.4 gmtx-ex4_4.htm EX-4.4 83144
3 EX-10.13 gmtx-ex10_13.htm EX-10.13 45595
4 EX-23.1 gmtx-ex23_1.htm EX-23.1 7437
5 EX-31.1 gmtx-ex31_1.htm EX-31.1 17181
6 EX-31.2 gmtx-ex31_2.htm EX-31.2 17116
7 EX-32.1 gmtx-ex32_1.htm EX-32.1 10051
8 EX-32.2 gmtx-ex32_2.htm EX-32.2 9996
  Complete submission text file 0000950170-22-003288.txt   10920181

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gmtx-20211231_cal.xml EX-101.CAL 49866
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gmtx-20211231.xsd EX-101.SCH 65623
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gmtx-20211231_pre.xml EX-101.PRE 415311
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gmtx-20211231_lab.xml EX-101.LAB 541459
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gmtx-20211231_def.xml EX-101.DEF 233471
82 EXTRACTED XBRL INSTANCE DOCUMENT gmtx-20211231_htm.xml XML 1620698
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39438 | Film No.: 22727381
SIC: 2834 Pharmaceutical Preparations